Click here to visit AstraZeneca’s website.
Speakers
Professor Jennifer Quint Professor of Respiratory Epidemiology, School of Public Health, Imperial College London
Professor Paul Kalra Professor of Cardiology, Portsmouth Hospitals NHS Trust, UK
Learning objectives
- Understand the epidemiology and diagnosis of patients with cardiopulmonary disease
- Recognise the common presentations and treatments for cardiopulmonary disease
- Explore foundational treatments for heart failure and respiratory diseases
Learning module instructions
This BJC TV learning module has a recommended award of 1 CPD credit for completion (1 hour of learning). Completion requires a score of at least 75%. If less time is spent learning, then you should claim a reduced credit value. After you have successfully completed the test, you will be able to download your certificate.
References
- Morgan AD et al. Ther Adv Respir Dis 2018;12:1753465817750524
- NHS. Treatment. Chronic obstructive pulmonary disease (COPD). 2023. Available at: https://www.nhs.uk/conditions/chronic-obstructive-pulmonary-disease-copd/treatment/ (accessed May 2024)
- Scanlon PD et al. Am J Respir Crit Care Med 2000;161:381–390
- Oelsner EC et al. Lancet Respir Med 2020;8:34–44
- Huang Q et al. PeerJ 2020;8:e10376
- Simon S et al. Eur Respir Rev 2023;32:230034
- NICE. Guidance: Chronic obstructive pulmonary disease in over 16s: diagnosis and management [NG115]. Last updated 26 July 2019. Available at: https://www.nice.org.uk/guidance/ng115/chapter/Recommendations#managing-stable-copd (accessed May 2024)
- GOLD. Global strategy for preventon, diagnosis and management of COPD: 2024 Report. 2024. Available at: https://goldcopd.org/2024-gold-report/ (accessed May 2024)
